Singapore biomed
Five things about Philip Yeo, former EDB chairman and outgoing CDL director
The economic heavyweight, whose 16-year tenure at CDL’s board ends on Jul 31, played key roles in building Jurong Island and the biomedical sector
Fu Yu Corp doubles down on biomedical bet
Added capabilities enable it to value-add and engage new customers, as well as pursue further collaborations with existing customers
Ho Bee Land sells 49% stake in Elementum for S$134 million to sovereign wealth fund
The company says the deal paves the way for broader collaboration, exploring new avenues for strategic growth and development
Singapore’s November factory output marks two straight months of growth, up lower-than-expected 1%
SINGAPORE’S manufacturing output gained 1 per cent on year in November, extending October’s surprise 7.6 per cent growth after a year-long slump.
Singapore’s October factory output rebounds with 7.4% growth after 12-month slump
SINGAPORE’S factory output in October surpassed market expectations with a 7.4 per cent year-on-year rebound after a year-long slump, data from the Singapore Economic Development Board (EDB) showed on...
Singapore biotech startups face funding drought, in search of patient capital
SINGAPORE biotech startups are struggling through a sharp drop in funding as investors seek greater certainty of returns.
What to watch in the biomedical space over the next five years
The pandemic has put the spotlight on the healthcare and biomedical sectors, driving unprecedented enthusiasm in the relatively unknown field of mRNA innovations, and bolstering growth in digital heal...
WuXi Biologics, WuXi AppTec to each invest S$2b to grow R&D, manufacturing capabilities in Singapore
WuXi Biologics, a contract research, development and manufacturing organisation, on Tuesday (Jul 19) announced a 10-year, S$2 billion investment plan to grow its presence in Singapore.
